Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Charles Peng, MD

Charles Peng, MD

  • Medical Director, Respiratory Care, UH Regional Hospitals Geauga Campus
  • Specialty: Pulmonary and Critical Care Medicine, Pulmonary Disease
  • Location:
    UH Geauga Health Center One
    13221 Ravenna Rd
    Chardon, OH 44024

Biography: Charles Peng, MD

Expertise

  • Bronchoscopy
  • Critical Care Medicine
  • Critical Care Ultrasonography
  • Endobronchial Ultrasound (EBUS)
  • Interstitial Lung Diseases
  • Lung Cancer
  • Pleural Diseases
  • Pleural Procedures
  • Pulmonary Hypertension
  • Pulmonary Medicine

Certifications & Memberships

  • Critical Care Medicine - American Board of Internal Medicine
  • Pulmonary Disease - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine

Education

Fellowship | Pulmonary/Critical Care
Pulmonary/Critical Care - Beth Israel Medical Center (2012 - 2015)

Residency | Internal Medicine
Internal Medicine - Beth Israel Medical Center (2008 - 2011)

Medical Education
The Ohio State University College Of Medicine (2008)

Undergraduate
Cornell University (2004)

About

Charles Peng, MD is the Medical Director for Respiratory Care at UH Geauga Medical Center. He completed medical school at The Ohio State University College of Medicine, residency at Mount Sinai Beth Israel Medical Center and Pulmonary/Critical Care fellowship at Mount Sinai Beth Israel Medical Center.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Charles Peng did not disclose any Outside Relationships with Industry.